Ashkon Software



NBS - Neostem, Inc.

Neostem, Inc. logo Neostem, Inc. (NBS) is a biopharmaceutical company that focuses on developing cellular therapies and regenerative medicine for patients with serious diseases and conditions. The company operates through two segments: a contract development and manufacturing organization (CDMO) and a development-stage therapeutics segment.

The CDMO segment provides services to clients in the cell therapy industry, including contract manufacturing services and engineering solutions. The therapeutics segment is focused on developing cellular therapies for patients with serious medical conditions, such as cancer and autoimmune disorders.

Neostem's lead product candidate is NBS20, a proprietary formulation of irinotecan for the treatment of metastatic colorectal cancer. The company is also developing a range of other cellular therapies, including immunomodulatory and regenerative medicines.

Founded in 1980, Neostem is headquartered in Ne




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer